Report NIH bars physicians who criticized sepsis trial from speaking with investigators

first_imgNational Institutes of Health Email By Jennifer Couzin-FrankelApr. 29, 2019 , 12:35 PM Two critical care physicians at the National Institute of Health (NIH) are being prevented by agency leadership from speaking to government investigators, who are exploring concerns around a large NIH-funded clinical trial, according to a report yesterday in The Wall Street Journal. The two physicians had raised concerns that the trial, which is testing treatments for the life-threatening blood infection sepsis, was putting patients at risk.Last year, the watchdog group Public Citizen in Washington, D.C., sent a letter raising concerns about the sepsis trial to the Office for Human Research Protections (OHRP) within the Department of Health and Human Services, NIH’s parent agency. Public Citizen stated that it had sought expert advice from the two NIH physicians, Charles Natanson and Peter Eichacker, in assessing the trial, and had concluded it posed “unacceptable risks” based on that assessment. In particular, Public Citizen charged that the study, Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis (CLOVERS), which began to recruit patients last year to test two novel sepsis treatments, didn’t include a control arm for the usual standard of care, putting participants at heightened risk of harm.The Wall Street Journal reports that OHRP then “launched a federal review of the conduct of the clinical trial, and sought to interview Drs. Natanson and Eichacker. NIH Director [Francis] Collins’s top assistant, Principal Deputy Director Lawrence A. Tabak, confirmed he prohibited the two doctors from answering questions from OHRP investigators.” (Neither   physician is involved in the trial.) Natanson has long spoken out against large clinical trials funded by his employer that recruit critically ill patients—sometimes in conjunction with his colleague Eichacker. Natanson’s targets have included a study of ventilator use that was suspended by OHRP in 2003 before being allowed to resume; a study of oxygen support in babies, which OHRP also investigated and against which Natanson testified; and more recently, an NIH trial to treat more than 3000 heart attack patients called the Myocardial Ischemia and Transfusion trial. In all of these cases, as in the CLOVERS trial, Natanson has argued that the trial’s design puts patients at a too-high risk, or otherwise comes with serious flaws.It is not clear when OHRP will conclude its review of the CLOVERS trial. In the meantime, recruitment of patients continues, with a goal of more than 2000 people.In a statement, NIH said the agency “has management discretion to assign employees to particular tasks based on their assigned, official duties, and will immediately assign appropriate staff to work with OHRP if OHRP seeks NIH expertise on this matter.”Update, 30 April 2019, 9:34 a.m.: This story has been updated to include a statement from NIH. Report: NIH bars physicians who criticized sepsis trial from speaking with investigators Sign up for our daily newsletter Get more great content like this delivered right to you! Country Click to view the privacy policy. Required fields are indicated by an asterisk (*) Country * Afghanistan Aland Islands Albania Algeria Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia, Plurinational State of Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Cote d’Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See (Vatican City State) Honduras Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea, Democratic People’s Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, the former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Martinique Mauritania Mauritius Mayotte Mexico Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Norway Oman Pakistan Palestine Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Qatar Reunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania, United Republic of Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Venezuela, Bolivarian Republic of Vietnam Virgin Islands, British Wallis and Futuna Western Sahara Yemen Zambia Zimbabwelast_img

Leave a Reply

Your email address will not be published. Required fields are marked *